Stockscreener 앱 받기
1.35
7.14%
0.09
시간 외 거래:
1.35
전일 마감가:
$1.26
열려 있는:
$1.45
하루 거래량:
10.42M
Relative Volume:
1.16
시가총액:
$405.11M
수익:
$188.87M
순이익/손실:
$-400.38M
주가수익비율:
-0.90
EPS:
-1.5
순현금흐름:
$-260.90M
1주 성능:
+1.50%
1개월 성능:
-10.00%
6개월 성능:
-13.46%
1년 성능:
-19.16%
1일 변동 폭
$1.2905
$1.51
1주일 범위
$1.25
$1.51
52주 변동 폭
$0.8511
$2.72
퍼시픽 바이오 사이언스 Stock (PACB) Company Profile
명칭
Pacific Biosciences Of California Inc
전화
650-521-8000
주소
1305 O'BRIEN DRIVE, MENLO PARK, CA
PACB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
1.35 | 414.12M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
퍼시픽 바이오 사이언스 Stock (PACB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-22 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-04-18 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-17 | 업그레이드 | UBS | Neutral → Buy |
| 2023-10-31 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-06-30 | 개시 | Goldman | Buy |
| 2023-05-10 | 개시 | Barclays | Equal Weight |
| 2023-03-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2023-01-20 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-21 | 재개 | Cantor Fitzgerald | Overweight |
| 2022-01-06 | 재개 | Piper Sandler | Neutral |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-09-27 | 개시 | Canaccord Genuity | Buy |
| 2021-02-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-02 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-03-09 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-10-15 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | 개시 | Cowen | Outperform |
| 2017-11-03 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | 다운그레이드 | CL King | Buy → Neutral |
| 2016-11-03 | 재확인 | Cantor Fitzgerald | Buy |
| 2016-06-27 | 개시 | CL King | Buy |
| 2016-04-15 | 개시 | First Analysis Sec | Overweight |
| 2016-02-04 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | 재확인 | Cantor Fitzgerald | Buy |
| 2015-10-23 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | 개시 | Cantor Fitzgerald | Buy |
| 2015-02-04 | 재확인 | Maxim Group | Buy |
| 2013-09-26 | 재확인 | Maxim Group | Buy |
| 2013-01-14 | 재확인 | Maxim Group | Buy |
모두보기
퍼시픽 바이오 사이언스 주식(PACB)의 최신 뉴스
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - sg.finance.yahoo.com
PacBio (PACB) Stock Trades Up, Here Is Why - TradingView
PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises - Nasdaq
Pacific Biosciences stock price target raised by Bernstein to $1.70 on clinical uptake - Investing.com Canada
Powered by PacBio: Selected publications from July 2025 - PacBio
Earnings call transcript: Pacific Biosciences Q2 2025 beats revenue expectations, stock surges - Investing.com Canada
Pacific Biosciences of California Q2 2025 Earnings Call Transcript - MarketBeat
Pacific Biosciences shares rise 11.11% premarket after reporting smaller-than-expected Q2 loss and positive trial data. - AInvest
PacBio Narrowed Losses As New Tech And China Deal Paid Off - Finimize
Pacific Biosciences of California Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - sharewise.com
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Pacific Biosciences: Q2 Earnings Snapshot - San Francisco Chronicle
PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars - Yahoo Finance
PacBio Announces Second Quarter 2025 Financial Results - GlobeNewswire
PacBio to Present at Upcoming Investor Conferences in August and September 2025 - Quiver Quantitative
PacBio to Present at Upcoming Investor Conferences - Stock Titan
PacBio (PACB) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
Pacific Biosciences of California Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Will Pacific Biosciences of California Inc. Reverse From Oversold ConditionsChart Driven High Reward Trading Setup Presented - beatles.ru
Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
PacBio and Collaborators Release Landmark Platinum Pedigree Dataset, Enhancing Genomic Variant Accuracy by 34% With AI Integration - Quiver Quantitative
Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models - Yahoo Finance
How strong is Pacific Biosciences of California Inc. company’s balance sheetGet expert advice on portfolio optimization - Jammu Links News
When is Pacific Biosciences of California Inc. stock expected to show significant growthOutstanding capital returns - Jammu Links News
What catalysts could drive Pacific Biosciences of California Inc. stock higher in 2025Invest smarter with expert trading signals - Jammu Links News
Should I hold or sell Pacific Biosciences of California Inc. stock in 2025Superior risk-adjusted returns - Jammu Links News
How does Pacific Biosciences of California Inc. generate profit in a changing economyAchieve rapid wealth accumulation with smart picks - Jammu Links News
What institutional investors are buying Pacific Biosciences of California Inc. stockUnprecedented profits - Jammu Links News
What are Pacific Biosciences of California Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
What is Pacific Biosciences of California Inc. company’s growth strategyExponential return rates - Jammu Links News
Is Pacific Biosciences of California Inc. a growth stock or a value stockAccess high-yield investment alerts now - Jammu Links News
What are analysts’ price targets for Pacific Biosciences of California Inc. in the next 12 monthsLightning-fast growth - Jammu Links News
Published on: 2025-08-03 06:22:09 - Jammu Links News
What is the dividend policy of Pacific Biosciences of California Inc. stockBuild a portfolio that delivers consistent profits - Jammu Links News
How Pacific Biosciences of California Inc. stock performs during market volatilityLow Risk Picks for Daily Trading Released - beatles.ru
Options Data Show Bullish Bias in Pacific Biosciences of California Inc.Conservative Long Term Growth Plans Under Review - metal.it
Does Pacific Biosciences of California Inc. stock perform well during market downturnsFinancial News Target Finder For Smart Trading - jammulinksnews.com
Customer success story: How Dr. Ibrahim Bitar is doubling his research impact while leading the future of European genomics from the Czech Republic - PacBio
Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings - MSN
Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN
What makes Pacific Biosciences of California Inc. stock price move sharplyPattern Breakout Entry Stock Forecast in Focus - metal.it
Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Pacific Biosciences Soars 6.5% Pre-Earnings Amid Restructuring Hopes - AInvest
Even after rising 13% this past week, Pacific Biosciences of California (NASDAQ:PACB) shareholders are still down 63% over the past three years - Yahoo Finance
Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing - MarketScreener
퍼시픽 바이오 사이언스 (PACB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):